BHI in the News BHI hires Ellen Raines as new Executive Administrator BioHealth Innovation, Inc. would like to welcome Ellen Raines, the newest addition to our team! She is responsible for supporting…BHI AdministratorJune 23, 2015
Bios William Hearl, Ph.D. Founder and CEO, Immunomic Therapeutics, Inc. Dr. William Hearl is the founder of Immunomic Therapeutics, Inc. and is an experienced and…BHI AdministratorJune 8, 2015
News BHI Client Company Avhana Health wins the 2015 Incubator Company of the Year Award The Incubator Company of the Year Awards is an opportunity to highlight Maryland's impressive incubator system and recognize the breadth…BHI AdministratorJune 5, 2015
News Emergent BioSolutions expands with new Headquarters in Gaithersburg Emergent BioSolutions recently cut the ribbon on a new headquarters in Gaithersburg which will add 130,000 square feet and 133…BHI AdministratorMay 26, 2015
BHI in the News BHI awards three companies in the Invest Maryland Challenge BHI issued a Commercial Relevance Award to three companies as part of the Invest Maryland Challenge, Maryland's statewide business plan…BHI AdministratorMay 12, 2015
BHI Press Releases BioHealth Innovation, ProductSavvy, and Montgomery County Launch Health-Tech Accelerator ROCKVILLE, MARYLAND, April 7, 2015 – To capitalize on the region's significant human capital and resources driving health innovation, BioHealth…BHI AdministratorApril 6, 2015
News Meet all your new healthcare investors thanks to SEC Regulation A+ The stage has been set for a disruptive return of the “Small IPO” to the private equity marketplace (Seed, Series…BHI AdministratorApril 2, 2015
News Baltimore Angels’ Investments grow to $100,000 per Deal – BBJ When serial entrepreneurs Greg Cangialosi and Dave Troy launched the Baltimore Angels in 2009, the small group of investors heard…BHI AdministratorApril 2, 2015
News TEDCO gets $500K Grant for Medical Device Commercialization Program – Technical.ly Another startup-focused program from TEDCO is on the way. The U.S. Economic Development Administration awarded the Maryland Technology Development Corporation…BHI AdministratorApril 2, 2015
News Thrasos Secures $21 Million to Complete Phase 2 Study of THR-184 in the Prevention of Acute Kidney Injury and Expand the Company’s Renal Portfolio – BusinessWeek Thrasos Therapeutics, a biotherapeutics company focused on delivering new solutions for kidney disease, today announced that it has completed a…BHI AdministratorApril 2, 2015